Market News AIOpen the app

OBIO stock news · Orchestra BioMed Hldgs

Stories about Orchestra BioMed Hldgs (OBIO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for OBIO

Follow Orchestra BioMed Hldgs (OBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for OBIO
Free on the App Store and Google Play, or on the web.
  1. Oct 23, 2026, 5:28 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Friday.

    Neutral

    Orchestra BioMed Hldgs shares fell 6.45% in the after-market session. The article gives no company update, so it does not change the outlook for Orchestra BioMed Hldgs' business.

  2. Oct 1, 2026, 8:48 AM ET · Market

    Orchestra BioMed says it signed up 330 patients for its important BACKBEAT study, beating its goal of 316.

    Good for OBIO

    Orchestra BioMed randomized 330 patients in its BACKBEAT trial, above its 316-patient target. This is positive progress, though treatment results and approval are still pending.

  3. Sep 10, 2026, 9:04 AM ET · Opinion

    A Meta expert is feeling positive; check out the five companies getting upgrades today.

    Good for OBIO

    Orchestra Biomed Holdings Inc was upgraded from Neutral to Buy and given a $10 price target. That upgrade is a bullish development for OBIO.

  4. Sep 8, 2026, 9:39 AM ET · Paperwork

    Orchestra BioMed Holdings, Inc. shares new investor presentation on its website.

    Neutral

    Orchestra BioMed Holdings, Inc. filed a Form 8-K with the SEC, disclosing a new investor presentation that is now available on its website.